669 669 Pill - purple capsule/oblong, 18mm
Pill with imprint 669 669 is Purple, Capsule/Oblong and has been identified as Diltiazem Hydrochloride Extended Release 120 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Heart Failure; High Blood Pressure; Angina Pectoris Prophylaxis and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 669 669
Diltiazem Hydrochloride Extended Release
- Imprint
- 669 669
- Strength
- 120 mg
- Color
- Purple
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 47335-0669
- Inactive Ingredients
-
hypromellose 2910 (5 mPa.s),
magnesium silicate,
ethylcellulose,
triethyl citrate,
gelatin,
titanium dioxide,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Red No. 3
Note: Inactive ingredients may vary.
Related images for "669 669"
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (187)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
- Diltiazem drug information
- Diltiazem 12-Hour Sustained-Release Capsules
- Diltiazem Long-Acting Capsules
Other brands
Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +6 more
Professional resources
- Diltiazem Hydrochloride monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Tiadylt ER, Dilt-XR, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.